Leah Lawrence | Authors

October 09, 2019

Switching from intravenous to subcutaneous administration of rituximab for non-Hodgkin diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma (FL) resulted in similar efficacy with no new safety issues.

October 09, 2019

The international retrospective study included 365 patients with newly diagnosed early-stage follicular lymphoma rigorously staged with PET-CT and bone marrow biopsy.

October 08, 2019

A survey of physicians found recruiting for trials through social media can be useful, but not for cancer therapeutic trials.

October 07, 2019

CAR T cells are a more effective therapy if manufactured for patients with multiple myeloma prior to the onset of relapsed or refractory disease.

October 07, 2019

Autologous stem cell transplant has become safer over the years for patients with multiple myeloma and renal insufficiency.

October 03, 2019

A combination of pegilodecakin (pegylated IL-10) with an anti-PD-L1 monoclonal antibody inhibitor showed preliminary antitumor activity.

October 01, 2019

After the FDA restricted the labels of 2 drugs used to treat bladder cancer, oncologists' use of these treatments decreased drastically.

September 30, 2019

Two studies from ESMO have potentially found treatments which can improve survival in HR-positive breast cancer.

September 30, 2019

Adding the immunotherapy pembrolizumab to neoadjuvant chemotherapy improved the pathological complete response rate in patients with early triple-negative breast cancer, according to findings of a study presented at ESMO.

September 24, 2019

MYC-rearrangement within 2 years after diagnosis may affect the prognosis of patients with diffuse large B-cell lymphoma.